$THRY
Thryv Holdings Inc

2021 Q2 Form 10-Q Financial Statement

#000162828021016601 Filed on August 11, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2 2020 Q1
Revenue $291.0M $303.6M $318.6M
YoY Change -4.14% -13.01% -21.94%
Cost Of Revenue $112.6M $110.6M $118.0M
YoY Change 1.81% -9.34% -11.43%
Gross Profit $178.4M $193.0M $200.6M
YoY Change -7.55% -14.97% -27.0%
Gross Profit Margin 61.31% 63.57% 62.97%
Selling, General & Admin $120.5M $123.3M $138.9M
YoY Change -2.27% -10.0% -2.42%
% of Gross Profit 67.53% 63.88% 69.22%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $29.93M $37.60M $37.80M
YoY Change -20.41% -28.11% -114.68%
% of Gross Profit 16.77% 19.48% 18.84%
Operating Expenses $120.5M $123.3M $138.9M
YoY Change -2.27% -34.9% -28.72%
Operating Profit $54.34M $51.58M $61.64M
YoY Change 5.35% 37.17% -22.95%
Interest Expense $19.17M $18.01M $19.93M
YoY Change 6.43% -171.76% -189.37%
% of Operating Profit 35.28% 34.92% 32.33%
Other Income/Expense, Net -$2.966M $955.0K $900.0K
YoY Change -410.58% -153.06% -150.0%
Pretax Income $32.47M $32.63M $41.51M
YoY Change -0.48% 472.42% -16.31%
Income Tax $8.112M $21.16M -$13.41M
% Of Pretax Income 24.98% 64.86% -32.3%
Net Earnings $24.36M $11.46M $28.10M
YoY Change 112.48% 247.39% -18.54%
Net Earnings / Revenue 8.37% 3.78% 8.82%
Basic Earnings Per Share $0.72 $0.36 $0.86
Diluted Earnings Per Share $0.66 $0.34 $0.80
COMMON SHARES
Basic Shares Outstanding 33.62M shares 31.44M shares 32.58M shares
Diluted Shares Outstanding 36.69M shares 33.80M shares 35.03M shares

Balance Sheet

Concept 2021 Q2 2020 Q2 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $15.79M $1.600M $1.200M
YoY Change 886.56%
Cash & Equivalents $15.79M $1.589M $1.203M
Short-Term Investments
Other Short-Term Assets $61.56M $50.10M $58.70M
YoY Change 22.87%
Inventory
Prepaid Expenses
Receivables $312.5M $389.8M $380.2M
Other Receivables $1.890M $36.00M $36.30M
Total Short-Term Assets $400.1M $477.4M $476.4M
YoY Change -16.19%
LONG-TERM ASSETS
Property, Plant & Equipment $76.32M $112.3M $137.5M
YoY Change -32.04%
Goodwill $678.8M
YoY Change
Intangibles $123.9M
YoY Change
Long-Term Investments
YoY Change
Other Assets $26.94M $11.90M $11.80M
YoY Change 126.42%
Total Long-Term Assets $1.012B $823.3M $877.4M
YoY Change 22.92%
TOTAL ASSETS
Total Short-Term Assets $400.1M $477.4M $476.4M
Total Long-Term Assets $1.012B $823.3M $877.4M
Total Assets $1.412B $1.301B $1.354B
YoY Change 8.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $30.02M $15.70M $14.00M
YoY Change 91.24%
Accrued Expenses $168.6M $189.7M $169.2M
YoY Change -11.12%
Deferred Revenue $32.23M
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $70.00M $700.0K $600.0K
YoY Change 9900.0%
Total Short-Term Liabilities $344.4M $282.1M $260.1M
YoY Change 22.07%
LONG-TERM LIABILITIES
Long-Term Debt $577.9M $713.8M $752.9M
YoY Change -19.04%
Other Long-Term Liabilities $44.76M $255.8M $268.1M
YoY Change -82.5%
Total Long-Term Liabilities $798.1M $969.6M $1.021B
YoY Change -17.69%
TOTAL LIABILITIES
Total Short-Term Liabilities $344.4M $282.1M $260.1M
Total Long-Term Liabilities $798.1M $969.6M $1.021B
Total Liabilities $1.142B $1.264B $1.320B
YoY Change -9.63%
SHAREHOLDERS EQUITY
Retained Earnings -$334.0M
YoY Change
Common Stock $604.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $468.6M
YoY Change
Treasury Stock Shares 26.68M shares
Shareholders Equity $269.7M $36.50M $33.89M
YoY Change
Total Liabilities & Shareholders Equity $1.412B $1.301B $1.354B
YoY Change 8.57%

Cashflow Statement

Concept 2021 Q2 2020 Q2 2020 Q1
OPERATING ACTIVITIES
Net Income $24.36M $11.46M $28.10M
YoY Change 112.48% 247.39% -18.54%
Depreciation, Depletion And Amortization $29.93M $37.60M $37.80M
YoY Change -20.41% -28.11% -114.68%
Cash From Operating Activities $67.60M $52.30M $45.64M
YoY Change 29.26% -10.9% -134.01%
INVESTING ACTIVITIES
Capital Expenditures -$10.61M -$3.900M -$9.100M
YoY Change 172.18% -2.5% -201.11%
Acquisitions $0.00
YoY Change
Other Investing Activities $73.00K $0.00 $1.500M
YoY Change -134.88%
Cash From Investing Activities -$10.54M -$3.900M -$7.620M
YoY Change 170.31% -2.5% -262.13%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $21.77M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -68.32M -48.00M -$38.73M
YoY Change 42.34% -86.75% -109.99%
NET CHANGE
Cash From Operating Activities 67.60M 52.30M $45.64M
Cash From Investing Activities -10.54M -3.900M -$7.620M
Cash From Financing Activities -68.32M -48.00M -$38.73M
Net Change In Cash -11.26M 400.0K -$709.0K
YoY Change -2915.25% -100.13% -100.27%
FREE CASH FLOW
Cash From Operating Activities $67.60M $52.30M $45.64M
Capital Expenditures -$10.61M -$3.900M -$9.100M
Free Cash Flow $78.22M $56.20M $54.74M
YoY Change 39.18% -10.37% -138.23%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
9500000 USD
dei Entity Central Index Key
EntityCentralIndexKey
0001556739
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.5555
CY2021Q2 us-gaap Defined Benefit Plan Type Extensible List
DefinedBenefitPlanTypeExtensibleList
us-gaap:PensionPlansDefinedBenefitMember
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-35895
dei Entity Registrant Name
EntityRegistrantName
THRYV HOLDINGS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
13-2740040
dei Entity Address Address Line1
EntityAddressAddressLine1
2200 West Airfield Drive, P.O. Box 619810
dei Entity Address City Or Town
EntityAddressCityOrTown
D/FW Airport
dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
75261
dei City Area Code
CityAreaCode
(972)
dei Local Phone Number
LocalPhoneNumber
453-7000
dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value per share
dei Trading Symbol
TradingSymbol
THRY
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
33865449 shares
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
291047000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
303612000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
571653000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
622182000 USD
CY2021Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
112607000 USD
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
110605000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
210767000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
228581000 USD
CY2021Q2 us-gaap Gross Profit
GrossProfit
178440000 USD
CY2020Q2 us-gaap Gross Profit
GrossProfit
193007000 USD
us-gaap Gross Profit
GrossProfit
360886000 USD
us-gaap Gross Profit
GrossProfit
393601000 USD
CY2021Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
87394000 USD
CY2020Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
79105000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
163934000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
168397000 USD
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
33100000 USD
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
44194000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
74379000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
93756000 USD
CY2021Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
3611000 USD
CY2020Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
18132000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
3611000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
18230000 USD
CY2021Q2 us-gaap Costs And Expenses
CostsAndExpenses
124105000 USD
CY2020Q2 us-gaap Costs And Expenses
CostsAndExpenses
141431000 USD
us-gaap Costs And Expenses
CostsAndExpenses
241924000 USD
us-gaap Costs And Expenses
CostsAndExpenses
280383000 USD
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
54335000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
51576000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
118962000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
113218000 USD
CY2021Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
14502000 USD
CY2020Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
13426000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
26109000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
28206000 USD
CY2021Q2 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
4668000 USD
CY2020Q2 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
4586000 USD
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
8733000 USD
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
9736000 USD
CY2021Q2 us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
-272000 USD
CY2020Q2 us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
936000 USD
us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
-725000 USD
us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
1137000 USD
CY2021Q2 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
2966000 USD
CY2020Q2 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
0 USD
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
4059000 USD
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
0 USD
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
32471000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
32628000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
80786000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
74139000 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8112000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21164000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
19921000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
34573000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
24359000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
11464000 USD
us-gaap Net Income Loss
NetIncomeLoss
60865000 USD
us-gaap Net Income Loss
NetIncomeLoss
39566000 USD
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.72
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.36
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.82
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.24
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.66
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.34
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.72
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.15
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33622666 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31435941 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33367734 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32007114 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
36687030 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33803465 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35352445 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34414996 shares
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
24359000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
11464000 USD
us-gaap Net Income Loss
NetIncomeLoss
60865000 USD
us-gaap Net Income Loss
NetIncomeLoss
39566000 USD
CY2021Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-1478000 USD
CY2020Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
0 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-4445000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
0 USD
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
22881000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
11464000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
56420000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
39566000 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15785000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2406000 USD
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
21450000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
33030000 USD
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
312457000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
296570000 USD
CY2021Q2 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss Current
ContractWithCustomerAssetAccumulatedAllowanceForCreditLossCurrent
157000 USD
CY2020Q4 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss Current
ContractWithCustomerAssetAccumulatedAllowanceForCreditLossCurrent
338000 USD
CY2021Q2 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
8415000 USD
CY2020Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
10975000 USD
CY2021Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
1890000 USD
CY2020Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
9229000 USD
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
36370000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
26172000 USD
CY2021Q2 dxm Indemnification Asset Current
IndemnificationAssetCurrent
25190000 USD
CY2020Q4 dxm Indemnification Asset Current
IndemnificationAssetCurrent
24346000 USD
CY2021Q2 us-gaap Assets Current
AssetsCurrent
400107000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
369698000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
76315000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
89044000 USD
CY2021Q2 us-gaap Goodwill
Goodwill
678793000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
609457000 USD
CY2021Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
123907000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
31777000 USD
CY2021Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
106069000 USD
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
93099000 USD
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
26944000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
21902000 USD
CY2021Q2 us-gaap Assets
Assets
1412135000 USD
CY2020Q4 us-gaap Assets
Assets
1214977000 USD
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
30024000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
8927000 USD
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
168602000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
139613000 USD
CY2021Q2 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
30615000 USD
CY2020Q4 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
30022000 USD
CY2021Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
32233000 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
18942000 USD
CY2021Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
70000000 USD
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 USD
CY2021Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
12898000 USD
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
9896000 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
344372000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
207400000 USD
CY2021Q2 us-gaap Senior Long Term Notes
SeniorLongTermNotes
365189000 USD
CY2021Q2 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
154697000 USD
CY2020Q4 us-gaap Senior Long Term Notes
SeniorLongTermNotes
335683000 USD
CY2020Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
113482000 USD
CY2021Q2 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
58022000 USD
CY2020Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
79238000 USD
CY2021Q2 dxm Financing Obligations Noncurrent
FinancingObligationsNoncurrent
0 USD
CY2020Q4 dxm Financing Obligations Noncurrent
FinancingObligationsNoncurrent
54798000 USD
CY2021Q2 us-gaap Defined Benefit Pension Plan Liabilities Noncurrent
DefinedBenefitPensionPlanLiabilitiesNoncurrent
174217000 USD
CY2020Q4 us-gaap Defined Benefit Pension Plan Liabilities Noncurrent
DefinedBenefitPensionPlanLiabilitiesNoncurrent
190827000 USD
CY2021Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1179000 USD
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
508000 USD
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
44756000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
36266000 USD
CY2021Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
798060000 USD
CY2020Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
810802000 USD
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
60391597 shares
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
33713187 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
59590422 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32912012 shares
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
604000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
596000 USD
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1076124000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1059624000 USD
CY2021Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
26678410 shares
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
26678410 shares
CY2021Q2 us-gaap Treasury Stock Value
TreasuryStockValue
468613000 USD
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
468613000 USD
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4445000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
0 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-333967000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-394832000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
269703000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
196775000 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1412135000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1214977000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
229196000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2024000 USD
CY2021Q2 dxm Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
13681000 USD
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1921000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
24359000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
269703000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
33892000 USD
CY2020Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
8856000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
11464000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
36500000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
196775000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-1070000 USD
dxm Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
13686000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3892000 USD
us-gaap Net Income Loss
NetIncomeLoss
60865000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
269703000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
27260000 USD
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
30626000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
300000 USD
us-gaap Net Income Loss
NetIncomeLoss
39566000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
36500000 USD
us-gaap Net Income Loss
NetIncomeLoss
60865000 USD
us-gaap Net Income Loss
NetIncomeLoss
39566000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
49626000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
75429000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1930000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
534000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-51439000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-42150000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
292000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
22436000 USD
dxm Provision For Service Credits
ProvisionForServiceCredits
8719000 USD
dxm Provision For Service Credits
ProvisionForServiceCredits
17197000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
3892000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
-5484000 USD
us-gaap Pension Expense Reversal Of Expense Noncash
PensionExpenseReversalOfExpenseNoncash
-725000 USD
us-gaap Pension Expense Reversal Of Expense Noncash
PensionExpenseReversalOfExpenseNoncash
1137000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-3409000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
44000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-3491000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
3611000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
18230000 USD
dxm Gain Loss On Remeasurement Of Indemnification Asset
GainLossOnRemeasurementOfIndemnificationAsset
844000 USD
dxm Gain Loss On Remeasurement Of Indemnification Asset
GainLossOnRemeasurementOfIndemnificationAsset
-4418000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-640000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
0 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
17000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-70491000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
28791000 USD
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-2402000 USD
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
2050000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
7567000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3177000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-51133000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-67064000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
3258000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
64821000 USD
dxm Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-3482000 USD
dxm Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-2407000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-13157000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-3544000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
81802000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
97871000 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
14315000 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
12975000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
63000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1502000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
174190000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-188442000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11473000 USD
us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
418070000 USD
us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
0 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
260930000 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 USD
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
545809000 USD
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
606455000 USD
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
567025000 USD
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
596969000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
30626000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
3305000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-191000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
123479000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-86721000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-819000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
16020000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-323000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2406000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1912000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18426000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1589000 USD
us-gaap Interest Paid Net
InterestPaidNet
37608000 USD
us-gaap Interest Paid Net
InterestPaidNet
39671000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
38411000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
11902000 USD
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
110605000 USD
CY2020Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
79105000 USD
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
44194000 USD
CY2020Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
18132000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
228581000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
168397000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
93756000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
18230000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the Company’s condensed consolidated financial statements requires management to make estimates and assumptions about future events that affect the amounts reported and disclosed in the condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable. The results of those estimates form the basis for making judgments about the carrying values of certain assets and liabilities.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="margin-top:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Examples of reported amounts that rely on significant estimates include revenue recognition, allowance for credit losses, assets acquired and liabilities assumed in business combinations, capitalized costs to obtain a contract, certain amounts relating to the accounting for income taxes, including valuation allowance, indemnification asset, stock-based compensation expense, operating lease right-of-use assets and operating lease liabilities, accrued service credits, and net pension obligation. Significant estimates are also used in determining the recoverability and fair value of fixed assets and capitalized software, operating lease right-of-use assets, goodwill and intangible assets.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the novel strain of coronavirus, commonly referred to as COVID-19 (“</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">COVID-19</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">”) and the uncertainty of the extent of the impacts related thereto, certain estimates and assumptions may require increased judgment. As events continue to evolve and additional information becomes available, these estimates may change in future periods. It is difficult to predict what the ongoing impact of the pandemic will be on future periods.</span></div>
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15785000 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1589000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2406000 USD
CY2021Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
2641000 USD
CY2020Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
0 USD
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
0 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18426000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1589000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2406000 USD
CY2021Q2 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
3600000 USD
us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
3600000 USD
CY2020Q2 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
15200000 USD
us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
15300000 USD
us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
2900000 USD
CY2020Q2 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
2900000 USD
us-gaap Business Combination Pro Forma Information Revenue Of Acquiree Since Acquisition Date Actual
BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual
62300000 USD
us-gaap Business Combination Pro Forma Information Earnings Or Loss Of Acquiree Since Acquisition Date Actual
BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual
-20300000 USD
CY2021Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
4700000 USD
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
600000 USD
CY2020Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
6200000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
12300000 USD
CY2021Q2 dxm Revenue From Contract With Customer Excluding Assessed Tax Covid19 Credits
RevenueFromContractWithCustomerExcludingAssessedTaxCOVID19Credits
800000 USD
dxm Revenue From Contract With Customer Excluding Assessed Tax Covid19 Credits
RevenueFromContractWithCustomerExcludingAssessedTaxCOVID19Credits
3000000.0 USD
CY2020Q2 dxm Revenue From Contract With Customer Excluding Assessed Tax Covid19 Credits
RevenueFromContractWithCustomerExcludingAssessedTaxCOVID19Credits
5700000 USD
dxm Revenue From Contract With Customer Excluding Assessed Tax Covid19 Credits
RevenueFromContractWithCustomerExcludingAssessedTaxCOVID19Credits
6400000 USD
CY2020Q2 dxm Deferred Compensation And Unrecognized Share Based Arrangements Liability Fair Value Disclosure
DeferredCompensationAndUnrecognizedShareBasedArrangementsLiabilityFairValueDisclosure
49500000 USD
CY2020Q2 us-gaap Deferred Compensation Sharebased Arrangements Liability Classified Noncurrent
DeferredCompensationSharebasedArrangementsLiabilityClassifiedNoncurrent
37300000 USD
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1900000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3900000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
-5500000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
609457000 USD
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
71931000 USD
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-2595000 USD
CY2021Q2 us-gaap Goodwill
Goodwill
678793000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1050372000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
922554000 USD
CY2021Q2 dxm Finite Lived Intangible Assets Accumulated Foreign Currency Gain Loss
FiniteLivedIntangibleAssetsAccumulatedForeignCurrencyGainLoss
3911000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
123907000 USD
us-gaap Finite Lived Intangible Assets Remaining Amortization Period1
FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
P3Y
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
923199000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
891422000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
31777000 USD
CY2020 us-gaap Finite Lived Intangible Assets Remaining Amortization Period1
FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
P2Y
CY2021Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
21000000.0 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
30900000 USD
CY2020Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
28900000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
57800000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
42200000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
50835000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
21926000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
8946000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
123907000 USD
CY2020Q4 dxm Accounts Receivable And Contract With Customer Allowance For Credit Loss
AccountsReceivableAndContractWithCustomerAllowanceForCreditLoss
33368000 USD
CY2019Q4 dxm Accounts Receivable And Contract With Customer Allowance For Credit Loss
AccountsReceivableAndContractWithCustomerAllowanceForCreditLoss
26828000 USD
dxm Accounts Receivable And Contract With Customer Allowance For Credit Loss Increase Due To Acquisition
AccountsReceivableAndContractWithCustomerAllowanceForCreditLossIncreaseDueToAcquisition
2733000 USD
dxm Accounts Receivable And Contract With Customer Credit Loss Expense Reversal
AccountsReceivableAndContractWithCustomerCreditLossExpenseReversal
292000 USD
dxm Accounts Receivable And Contract With Customer Credit Loss Expense Reversal
AccountsReceivableAndContractWithCustomerCreditLossExpenseReversal
22436000 USD
dxm Accounts Receivable And Contract With Customer Allowance For Credit Loss Writeoff
AccountsReceivableAndContractWithCustomerAllowanceForCreditLossWriteoff
14787000 USD
dxm Accounts Receivable And Contract With Customer Allowance For Credit Loss Writeoff
AccountsReceivableAndContractWithCustomerAllowanceForCreditLossWriteoff
12635000 USD
CY2021Q2 dxm Accounts Receivable And Contract With Customer Allowance For Credit Loss
AccountsReceivableAndContractWithCustomerAllowanceForCreditLoss
21606000 USD
CY2020Q2 dxm Accounts Receivable And Contract With Customer Allowance For Credit Loss
AccountsReceivableAndContractWithCustomerAllowanceForCreditLoss
36629000 USD
dxm Accounts Receivable And Contract With Customer Credit Loss Expense Reversal
AccountsReceivableAndContractWithCustomerCreditLossExpenseReversal
300000 USD
CY2021Q2 dxm Accounts Receivable And Contract With Customer Credit Loss Expense Reversal
AccountsReceivableAndContractWithCustomerCreditLossExpenseReversal
-1700000 USD
dxm Accounts Receivable And Contract With Customer Credit Loss Expense Reversal
AccountsReceivableAndContractWithCustomerCreditLossExpenseReversal
22400000 USD
CY2020Q2 dxm Accounts Receivable And Contract With Customer Credit Loss Expense Reversal
AccountsReceivableAndContractWithCustomerCreditLossExpenseReversal
11800000 USD
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
21400000 USD
CY2021Q2 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss
ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
200000 USD
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
36200000 USD
CY2020Q2 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss
ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
400000 USD
CY2020Q2 dxm Accounts Receivable Allowance For Credit Loss Incremental Increase Decrease Due To Covid19
AccountsReceivableAllowanceForCreditLossIncrementalIncreaseDecreaseDueToCOVID19
2000000.0 USD
dxm Accounts Receivable Allowance For Credit Loss Incremental Increase Decrease Due To Covid19
AccountsReceivableAllowanceForCreditLossIncrementalIncreaseDecreaseDueToCOVID19
5100000 USD
dxm Accounts Receivable Allowance For Credit Loss Incremental Increase Decrease Due To Covid19
AccountsReceivableAllowanceForCreditLossIncrementalIncreaseDecreaseDueToCOVID19
0 USD
CY2021Q2 dxm Accounts Receivable Allowance For Credit Loss Incremental Increase Decrease Due To Covid19
AccountsReceivableAllowanceForCreditLossIncrementalIncreaseDecreaseDueToCOVID19
0 USD
CY2021Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
50779000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
53844000 USD
CY2021Q2 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
872000 USD
CY2020Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
2280000 USD
CY2021Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
48571000 USD
CY2020Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
26209000 USD
CY2021Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
63398000 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
51284000 USD
CY2021Q2 dxm Accrued Service Credits Current
AccruedServiceCreditsCurrent
4982000 USD
CY2020Q4 dxm Accrued Service Credits Current
AccruedServiceCreditsCurrent
5996000 USD
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
168602000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
139613000 USD
CY2021Q2 us-gaap Severance Costs1
SeveranceCosts1
566000 USD
us-gaap Severance Costs1
SeveranceCosts1
1170000 USD
CY2020Q2 us-gaap Severance Costs1
SeveranceCosts1
4005000 USD
us-gaap Severance Costs1
SeveranceCosts1
7349000 USD
CY2021Q2 us-gaap Payments For Restructuring
PaymentsForRestructuring
913000 USD
us-gaap Payments For Restructuring
PaymentsForRestructuring
2314000 USD
CY2020Q2 us-gaap Payments For Restructuring
PaymentsForRestructuring
4167000 USD
us-gaap Payments For Restructuring
PaymentsForRestructuring
6554000 USD
CY2021Q2 us-gaap Long Term Debt
LongTermDebt
647908000 USD
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
528403000 USD
CY2021Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
70000000 USD
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 USD
CY2021Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
577908000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
528403000 USD
CY2021Q2 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
4700000 USD
CY2020Q2 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
4600000 USD
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
8700000 USD
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
9700000 USD
CY2021Q2 us-gaap Interest Payable Current
InterestPayableCurrent
3400000 USD
CY2020Q4 us-gaap Interest Payable Current
InterestPayableCurrent
8500000 USD
CY2021Q2 dxm Repayments Of Financing Obligations
RepaymentsOfFinancingObligations
10200000 USD
CY2021Q2 dxm Financing Obligation Right Of Use Asset Writeoff
FinancingObligationRightOfUseAssetWriteoff
48100000 USD
CY2021Q2 dxm Financing Obligation Writeoff
FinancingObligationWriteoff
55200000 USD
CY2021Q2 dxm Gain Loss On Extinguishment Of Financing Obligation
GainLossOnExtinguishmentOfFinancingObligation
-3100000 USD
dxm Gain Loss On Extinguishment Of Financing Obligation
GainLossOnExtinguishmentOfFinancingObligation
-3100000 USD
CY2021Q2 dxm Financing Obligations Noncash Residual Value Of Failed Sale Leaseback Transaction
FinancingObligationsNoncashResidualValueOfFailedSaleLeasebackTransaction
0 USD
CY2020Q4 dxm Financing Obligations Noncash Residual Value Of Failed Sale Leaseback Transaction
FinancingObligationsNoncashResidualValueOfFailedSaleLeasebackTransaction
54676000 USD
CY2021Q2 dxm Financing Obligations Minimum Lease Payments Failed Sale Leaseback Transaction
FinancingObligationsMinimumLeasePaymentsFailedSaleLeasebackTransaction
0 USD
CY2020Q4 dxm Financing Obligations Minimum Lease Payments Failed Sale Leaseback Transaction
FinancingObligationsMinimumLeasePaymentsFailedSaleLeasebackTransaction
862000 USD
CY2021Q2 dxm Financing Obligations
FinancingObligations
0 USD
CY2020Q4 dxm Financing Obligations
FinancingObligations
55538000 USD
CY2021Q2 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
2618000 USD
CY2020Q2 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
4199000 USD
us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
5234000 USD
us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
8433000 USD
CY2021Q2 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
2890000 USD
CY2020Q2 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
4026000 USD
us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
149865 shares
us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
5780000 USD
us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
8059000 USD
CY2021Q2 us-gaap Defined Benefit Plan Recognized Net Gain Loss Due To Settlements1
DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
0 USD
CY2020Q2 us-gaap Defined Benefit Plan Recognized Net Gain Loss Due To Settlements1
DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
-24000 USD
us-gaap Defined Benefit Plan Recognized Net Gain Loss Due To Settlements1
DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
15000 USD
us-gaap Defined Benefit Plan Recognized Net Gain Loss Due To Settlements1
DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
-24000 USD
CY2021Q2 us-gaap Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
0 USD
CY2020Q2 us-gaap Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
-739000 USD
us-gaap Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
164000 USD
us-gaap Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
-739000 USD
CY2021Q2 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
-272000 USD
CY2020Q2 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
936000 USD
us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
-725000 USD
us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
1137000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
239275 shares
CY2021Q2 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
149865 shares
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1921000 USD
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
580000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3892000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
-5484000 USD
CY2021Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
9400000 shares
CY2020Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
10500000 shares
CY2021Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
5200000 shares
CY2020Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
5800000 shares
CY2021Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
24.39
CY2020Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
24.39
CY2021Q2 dxm Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights During Period
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsDuringPeriod
1011224 shares
dxm Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights During Period
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsDuringPeriod
1011424 shares
CY2020Q2 dxm Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights During Period
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsDuringPeriod
0 shares
dxm Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights During Period
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsDuringPeriod
0 shares
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
13700000 USD
CY2021Q2 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
13700000 USD
CY2020Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
1000000.0 shares
CY2020Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
12600000 USD
CY2020Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
800000 shares
CY2020Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
9200000 USD
CY2020Q2 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
800000 shares
CY2020Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
8800000 USD
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0 shares
CY2021Q2 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0 shares
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
24359000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
11464000 USD
us-gaap Net Income Loss
NetIncomeLoss
60865000 USD
us-gaap Net Income Loss
NetIncomeLoss
39566000 USD
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33622666 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31435941 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33367734 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32007114 shares
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.72
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.36
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.82
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.24
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
24359000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
11464000 USD
us-gaap Net Income Loss
NetIncomeLoss
60865000 USD
us-gaap Net Income Loss
NetIncomeLoss
39566000 USD
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33622666 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31435941 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33367734 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32007114 shares
CY2021Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
3064364 shares
CY2020Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2367524 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1984711 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2407882 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
36687030 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33803465 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35352445 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34414996 shares
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.66
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.34
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.72
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.15
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2021Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.250
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.247
CY2020Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.649
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.466
CY2021Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
23500000 USD
CY2021Q2 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
23500000 USD
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
23700000 USD
CY2020Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
23700000 USD
CY2021Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
23500000 USD
CY2021Q2 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
23500000 USD
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
23700000 USD
CY2020Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
23700000 USD
CY2021Q2 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
9200000 USD
CY2020Q4 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
8400000 USD
CY2021Q2 us-gaap Decrease In Unrecognized Tax Benefits Is Reasonably Possible
DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
21600000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
1500000 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3 segment
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
291047000 USD
CY2021Q2 dxm Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
96753000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
303612000 USD
CY2020Q2 dxm Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
118135000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
571653000 USD
dxm Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
201686000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
622182000 USD
dxm Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
230914000 USD
CY2021Q2 dxm Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
96753000 USD
CY2020Q2 dxm Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
118135000 USD
dxm Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
201686000 USD
dxm Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
230914000 USD
CY2021Q2 us-gaap Interest Expense
InterestExpense
19170000 USD
CY2020Q2 us-gaap Interest Expense
InterestExpense
18012000 USD
us-gaap Interest Expense
InterestExpense
34842000 USD
us-gaap Interest Expense
InterestExpense
37942000 USD
CY2021Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
29908000 USD
CY2020Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
37606000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
49626000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
75429000 USD
CY2021Q2 us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
-272000 USD
CY2020Q2 us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
936000 USD
us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
-725000 USD
us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
1137000 USD
CY2021Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-3110000 USD
CY2020Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-3409000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2021Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
3611000 USD
CY2020Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
18132000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
3611000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
18230000 USD
CY2021Q2 dxm Restructuring Charges And Integration Expenses
RestructuringChargesAndIntegrationExpenses
3489000 USD
CY2020Q2 dxm Restructuring Charges And Integration Expenses
RestructuringChargesAndIntegrationExpenses
7347000 USD
dxm Restructuring Charges And Integration Expenses
RestructuringChargesAndIntegrationExpenses
12723000 USD
dxm Restructuring Charges And Integration Expenses
RestructuringChargesAndIntegrationExpenses
17192000 USD
CY2021Q2 dxm Transaction Costs
TransactionCosts
5440000 USD
CY2020Q2 dxm Transaction Costs
TransactionCosts
3232000 USD
dxm Transaction Costs
TransactionCosts
15986000 USD
dxm Transaction Costs
TransactionCosts
9766000 USD
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1921000 USD
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
580000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3892000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
-5484000 USD
CY2021Q2 dxm Gain Loss On Remeasurement Of Indemnification Asset
GainLossOnRemeasurementOfIndemnificationAsset
844000 USD
CY2020Q2 dxm Gain Loss On Remeasurement Of Indemnification Asset
GainLossOnRemeasurementOfIndemnificationAsset
-617000 USD
dxm Gain Loss On Remeasurement Of Indemnification Asset
GainLossOnRemeasurementOfIndemnificationAsset
844000 USD
dxm Gain Loss On Remeasurement Of Indemnification Asset
GainLossOnRemeasurementOfIndemnificationAsset
-4418000 USD
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1251000 USD
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
955000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1620000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1855000 USD
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
32471000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
32628000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
80786000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
74139000 USD
CY2021Q2 us-gaap Severance Costs1
SeveranceCosts1
600000 USD
us-gaap Severance Costs1
SeveranceCosts1
1200000 USD
CY2020Q2 us-gaap Severance Costs1
SeveranceCosts1
4000000.0 USD
us-gaap Severance Costs1
SeveranceCosts1
7300000 USD
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
291047000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
303612000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
571653000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
622182000 USD

Files In Submission

Name View Source Status
0001628280-21-016601-index-headers.html Edgar Link pending
0001628280-21-016601-index.html Edgar Link pending
0001628280-21-016601.txt Edgar Link pending
0001628280-21-016601-xbrl.zip Edgar Link pending
dxm-20210630.htm Edgar Link pending
dxm-20210630.xsd Edgar Link pending
dxm-20210630_cal.xml Edgar Link unprocessable
dxm-20210630_def.xml Edgar Link unprocessable
dxm-20210630_htm.xml Edgar Link completed
dxm-20210630_lab.xml Edgar Link unprocessable
dxm-20210630_pre.xml Edgar Link unprocessable
exhibit311-q22021.htm Edgar Link pending
exhibit312-q22021.htm Edgar Link pending
exhibit321-q22021.htm Edgar Link pending
exhibit322-q22021.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending